bluebird bio (NASDAQ:BLUE) has observed the following analyst ratings within the last quarter: According to 4 analyst offering 12-month price targets in the last 3 months, bluebird bio has an average price target of $7.25 with a high of $9.00 and a low of $4.00. Below is a summary of how these 4 analysts rated bluebird bio over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stockThis current average represents a 75.83% decrease from the previous average price target of $30.00.
What 4 Analyst Ratings Have To Say About Bluebird Bio
Benzinga Real-time News · 01/25 04:02
Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.